The U.S. Food and Drug Administration approved the first naloxone nasal spray product available without a prescription.
Similar Posts
Matrixx Initiatives Inc. (Zicam), Scottsdale, AZ 483 issued 5/28/2009 (1 page)
Matrixx Initiatives Inc. (Zicam), Scottsdale, AZ 483 issued 5/28/2009 (1 page)Southwind Foods, LLC Recalls Frozen Shrimp Because of Possible Health Risk
Southwind Foods, LLC of Carson, California is voluntarily recalling a limited quantity of Frozen Shrimp, due to possible radionuclide (Cesium-137) contamination. Cs-137 is a man-made radioisotope of cesium. Traces of Cs-137 are widespread and can be present in the environment at background levels, aChemspec Chemicals Private Limited – 718403 – 12/23/2025
CGMP/Active Pharmaceutical Ingredient (API)/AdulteratedCDER and CBER accept first submission to ISTAND Pilot Program
FDA’s Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) have accepted the agency’s first submission into the Innovative Science and Technology Approaches for New Drugs (ISTAND) Pilot Program.Food To Live Voluntarily Recalls Organic Moringa Products Because of Possible Health Risk
Brooklyn, NY – Food To Live, of Brooklyn, NY, is recalling its packaged Organic Moringa Leaf Powder (dried Moringa oleifera) and its Organic Supergreens Powder Mix distributed under the Food To Live brand that are in the following sizes:Division of Oncology 2 (DO2)
The Division of Oncology 2 (DO2) regulates Investigational New Drug Applications (INDs), New Drug Applications (NDAs) and Biologic Licensing Applications (BLAs) for the following therapeutic areas: gastrointestinal, lung, and head and neck cancers; neuro-oncology, rare cancers, pediatric